Medexus Pharmaceuticals (MDP) Stock Price, News & Analysis

Company Overview

Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus's current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.

Key Stats

• Today's Range: C$5.40 to C$5.69
• 50-Day Range: C$4.72 to C$5.69
• 52-Week Range: C$2.51 to C$5.72
• Volume: 19,652 shs
• Average Volume: 45,449 shs
• Market Capitalization: C$170.96 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: TSE:MDP
• CIK: N/A
• Web: www.medexus.com
• Phone: 877-633-3987
• Fax: N/A
• Employees: 90
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$3.26 million
• Net Margins: -2.29%
• Pretax Margin: N/A
• Return on Equity: -4.69%
• Return on Assets: 4.89%

Debt

• Debt-to-Equity Ratio: 54.62
• Current Ratio: 1.30
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$103.30 million
• Price / Sales: 1.65
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$1.51 per share
• Price / Book: 3.61

Miscellaneous

• Outstanding Shares: 31,426,000
• Free Float: N/A
• Market Cap: C$170.96 million
• Optionable: Not Optionable
• Beta: 0.12